BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 56 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,000 | -25.0% | 4,178 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | 0.0% | 4,178 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -11.1% | 4,178 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | – | 4,178 | +11837.1% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 35 | -98.5% | 0.00% | – |
| Q3 2014 | $6,000 | -25.0% | 2,357 | -15.9% | 0.00% | – |
| Q2 2014 | $8,000 | -52.9% | 2,801 | -1.2% | 0.00% | – |
| Q1 2014 | $17,000 | +70.0% | 2,836 | +20.3% | 0.00% | – |
| Q4 2013 | $10,000 | +233.3% | 2,357 | +199.5% | 0.00% | – |
| Q3 2013 | $3,000 | 0.0% | 787 | +6.9% | 0.00% | – |
| Q2 2013 | $3,000 | – | 736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
| Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
| Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
| TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
| Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
| BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
| Perceptive Advisors | 253,400 | $722,000 | 0.07% |
| BAILARD, INC. | 115,000 | $328,000 | 0.05% |
| KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |